Back to top

aTyr Pharma Lawsuit: Company Asks Court to Dismiss Investor Securities Claims 

aTyr Pharma (ATYR) and two executives have asked a federal court to dismiss an amended investor lawsuit over statements tied to the company’s efzof...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

aTyr Pharma, Inc. (ATYR)